Top Healthcare Stocks for November 2022

Top Healthcare Stocks for November 2022

Instead, look at Bausch Health Companies, which has a very rocky backstory but has managed to turn the corner. The global market for macular edema and macular degeneration market was valued at $8.3 billion in 2020 and is expected to reach $16.5 billion by 2030. 19.7% of the US GDP and the healthcare expenditure was about $4.1 trillion or $12,530 per person.

  • AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally.
  • Volatile investment conditions and a tight labor market, however, continue to present operating and financial challenges for healthcare leaders.
  • HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
  • We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.

The stock has trended higher in the past five years and is about 20% off its highest price. Pfizer is producing medication for COVID-19 and other diseases and has a long history of solid performance. Acadia Healthcare focuses on providing mental health care to patients across the country. It focuses on providing special psychiatric care and addiction treatment in various settings. The company is poised for growth as the emotional toll of the pandemic drove more people to seek out therapy in large numbers.

Health Care Stock #3: Baxter International (BAX)

These companies create, manufacture, and market the medicines we take when we’re sick. By the time the company realized that it was being impersonated, LLY stock had already started falling. And, as it trended downward, many of its healthcare peers followed suit. While shares have since rebounded slightly this afternoon, it remains a bad day for healthcare stocks across the board.

healthcare stocks

Once an exclusivity period expires, any other company can sell that therapy under a generic brand name, cutting a deep hole into the revenue generated by the original drug developer. Successful investors will generally tell you they avoid investments in companies that do things they’re not interested in. To make money in the market, you have to be willing to do research into the companies that you’re buying pieces of. But as great as investing in this industry can be, it can also be dangerous.

Also, while established health care companies are known for strong long-term growth, they are not known for momentous growth. Riskier, clinical-stage biotech companies may scratch this itch, but there are far less risky plays with which to take advantage of momentum. For example, according to CNBC, Apple has spent years building internal medical teams. These teams have developed health care software, hardware, and — most recently — health care provider locations. Should any of these clinical trials go wrong for a company, its stock may experience a dramatic decline in value.

Morningstar Rating for Stocks

UnitedHealth Group is the biggest publicly traded health insurance company in the U.S. by market capitalization. Through its network of companies, UnitedHealth offers numerous health insurance plans as well as owns Optum, which provides, among other things, healthcare benefits like health savings accounts . While the health care industry is generally an enjoyable and entertaining industry to research, there is a drawback.

The sector is a safe bet for long-term growth, but which health-care stocks stand to gain the most? While healthcare stocks will bounce back, the future of Twitter remains much more questionable. The fact that a parody account of a well-known company was able to gain verification and fool many users doesn’t bode well for the platform’s credibility.

healthcare stocks

Full BioNathan Reiff has been writing expert articles and news about financial topics such as investing and trading, cryptocurrency, ETFs, and alternative investments on Investopedia since 2016. For example, if you’re looking for a stable growth stock that pays dividends and comes with a relatively low level of risk, you would likely dive into a blue-chip stock like Johnson & Johnson. This stock has a long history of sustained growth and increasing dividends, fitting the bill for exactly what you want.

Some of the more popular healthcare wearable devices include smart health watches, ECG monitors, blood pressure monitors, and biosensors. A survey conducted by Insider Intelligence found U.S. consumers‘ use of healthcare wearables increased from 9% to 33% in the past four years and will continue to grow as new health-tracking technologies emerge. Because you believe the stock will continue to produce compelling growth, you decide to invest the entire $500 in the stock. Following this rule, let’s say you are interested in Johnson & Johnson — an established name in health care that’s known for consistent growth — which you believe will continue to provide tremendous opportunity. While some companies in the industry pay dividends, the average dividend yield in the industry is just 2.28% according to That pales in comparison to the 3.2% average dividend yield in the technology sector, the 3.96% average dividend yield in utilities, or the whopping 4.92% average dividend yield in the basic-materials sector.

It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. The general public always needs doctors and insurance companies, and the health care sector can help change the tide of your overall investment portfolio.

As a result, it’s more important than ever for you to do your research to get a full understanding of the company you’re buying into prior to making an investment in health care. There are quite a few companies in the health care category that sell a hope and a dream. For example, people understand the global health risks posed by AIDS and can get excited about the prospect of eradicating the disease. Moreover, application and software companies that create health-related mobile tradeallcrypto phone apps, companies that store medical data in a HIPPA-compliant way, and companies that produce technologies like thermal imaging for use in medical applications are all in the health care category. There are also several technology stocks that fall into the health care category. For example, the companies that create the technologies that make remote doctor’s appointments possible, like Teladoc, operate in the health care space just as much as they operate in the tech space.

The 7 Best Dividend Healthcare Stocks Now

Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors‘ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.

The fundamental appeal of the healthcare sector makes an Excel database of all healthcare stocks very useful. Keep reading this article to learn more about the merits of investing in healthcare stocks. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

healthcare stocks

Bristol-Myers Squibb is a U.S.-based, multinational pharmaceutical company that researches and manufactures medication for use at the prescription and over-the-counter levels. It’s a Fortune 500 company with annual revenue of $46.4 billion tradeallcrypto for the fiscal year 2021. The company has gained over 6% in the past five years and is at the forefront of medical innovation. Bristol-Myers Squibb was founded in 1887 and has shown its capability to be a medical innovation leader.

Stock Sector

Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. Instead, consider purchasing exchange-traded funds or index funds that track diversified indexes focused on the healthcare sector. These are less swayed by the individual ups and downs of any one company but provide solid, steady long-term growth.

Forward P/E ratios, which use earnings estimates for one year into the future, can be more helpful in assessing the valuation of fast-growing healthcare stocks. Comparing P/E ratios with other stocks in the same industry will help you determine if the stock is relatively cheap or relatively expensive. We sell different types of products and services to both investment professionals and individual investors.

Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company’s Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies.

Finally, capital deployment through Baxter’s significantly under-levered balance sheet. Several smaller bolt-on acquisitions were nicely complementary to the existing portfolio, but in early September the company announced the acquisition of Hil-Rom Holdings, a medical device company with leading positions in bed systems and patient monitoring. The deal is significant at US$12.5bn in size, and exhausts all balance sheet latency in one fell swoop. These trends include artificial intelligence being increasingly used by healthcare providers, healthcare becoming more personalized in terms of precision medicines, virtual healthcare becoming mainstream, and mental health being a priority, among others. Told research firm Deloitte recently that COVID-19 has accelerated numerous trends in the healthcare sector, particularly around health equity and sustainability.

Vertex Pharmaceuticals Incorporated was founded in 1989 and is headquartered in Boston, Massachusetts. We selected the following healthcare dividend stocks based on positive analyst coverage, strong business fundamentals, and robust dividend profiles. We have assessed the hedge fund sentiment from Insider Monkey’s database of 895 elite hedge beaxy funds tracked as of the end of the second quarter of 2022. Discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. On September 5, the company revealed that it had acquired NewMetrica, a Scottish animal health-related digital tool developer.

When news is released that one of these treatments did well in mice, it’s easy to think that the treatment will do well in humans and make it to market. Moreover, the road to FDA approval can be a long and costly one, further adding to the risk. However, for drugs that treat rare conditions or those that treat conditions with no other options on the market, exclusivity periods can be extended to up to seven years. On the other hand, if you’re willing to take on more risk and want to get in on a company on the ground floor for a potential opportunity to win big in the long run, you may look at Novavax. This company has multiple vaccine candidates under development, some in late stages, and seems to be changing the way we see influenza vaccination while also working on a COVID-19 vaccine candidate.